Vmn2r66 can be understood to interact with this protein by intervening in various signaling pathways and cellular processes that are requisite for its function. Phorbol 12-myristate 13-acetate can activate protein kinase C (PKC), which in turn can phosphorylate downstream proteins that lead to the internalization of Vmn2r66, reducing its presence on the cell surface and thus its activity. On the other hand, the broad-spectrum PKC inhibitor Gö 6983 can prevent this phosphorylation, thereby maintaining the localization and function of Vmn2r66. Staurosporine serves as a non-selective kinase inhibitor that can inhibit several kinases which may phosphorylate proteins that regulate Vmn2r66 activity, thus impeding its function. BAPTA-AM, as a calcium chelator, can limit calcium signaling, a necessary component of Vmn2r66-mediated signal transduction, thereby inhibiting the protein's activity. KN-93, by inhibiting Ca2+/calmodulin-dependent protein kinase II (CaMKII), can interfere with signaling mechanisms that Vmn2r66 relies on, leading to its inhibition.
ML-7 can inhibit myosin light chain kinase (MLCK), potentially reducing actin cytoskeleton reorganization, which can influence Vmn2r66 function. Similarly, Y-27632 inhibits ROCK kinase, which can impact the cytoskeletal arrangement and hence affect Vmn2r66's signaling pathways. Bisindolylmaleimide I, another PKC inhibitor, can also prevent phosphorylation of proteins within Vmn2r66's operational pathways. U73122 targets phospholipase C, which generates second messengers like IP3 and DAG that are instrumental in the signaling cascade of Vmn2r66; its inhibition can therefore impede the protein's function. PD 98059 can inhibit MEK, which is upstream of ERK1/2, potentially reducing phosphorylation of proteins that regulate Vmn2r66 activity, thus leading to its functional inhibition. Finally, Wortmannin and LY294002 both inhibit PI3K, a kinase central to numerous signaling pathways, including those involving Vmn2r66. By blocking PI3K, these inhibitors can prevent crucial signaling that supports the proper function of Vmn2r66.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activation of protein kinase C (PKC) can phosphorylate downstream proteins that could lead to the internalization of Vmn2r66. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
A broad-spectrum PKC inhibitor, could prevent the phosphorylation of proteins involved in Vmn2r66 signaling, leading to inhibition. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A non-selective kinase inhibitor that can inhibit kinases which phosphorylate proteins affecting Vmn2r66 function. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
A calcium chelator that can inhibit calcium signaling thus potentially inhibiting Vmn2r66-mediated signal transduction. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
Inhibits Ca2+/calmodulin-dependent protein kinase II (CaMKII) which may be involved in Vmn2r66 signal transduction. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
Inhibits myosin light chain kinase (MLCK) which could reduce actin cytoskeleton reorganization affecting Vmn2r66 function. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibits ROCK kinase which is involved in cytoskeletal arrangement potentially affecting Vmn2r66 signaling pathways. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
A PKC inhibitor that could prevent the phosphorylation of proteins involved in the signaling pathways of Vmn2r66. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK which is upstream of ERK1/2, potentially reducing the phosphorylation of proteins that regulate Vmn2r66 activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K which is crucial for many signaling pathways including those that may involve Vmn2r66. | ||||||